Hyperacusis
MONDO:0043303A disorder in which an individual has an abnormally low noise tolerance, and increased sensitivity to sounds.
Also known as: hyperacusis, Phonophobias, auditory Hyperesthesias, auditory hyperesthesia, disturbance, loudness perception, disturbances, loudness perception, hyperacuses, hyperacusia
12 clinical trials for this condition and its sub-types, 10 tagged with Hyperacusis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hyperacusis
-
Noxacusis 0 trials
-
Could a dissolving tablet stop migraines in kids?
Disease control Recruiting nowThis study tests whether rimegepant, a dissolving tablet, can prevent migraines in children and adolescents ages 6 to under 18. About 640 participants will receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug reduces the number of migraine days p…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Sound therapy may retrain the ears of adults with autism to handle loud noises
Symptom relief Recruiting nowThis trial tests a personalized program called TIHA for adults with autism who find everyday sounds painfully loud, a condition known as loudness hyperacusis. The program combines counseling, safe sound management, and gradual exposure to therapeutic sounds. Researchers will rand…
Sponsor: University of Central Florida • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Migraine drug rimegepant tested for safety in kids and teens
Symptom relief Recruiting nowThis study tests the long-term safety of rimegepant, a migraine medication taken as a dissolving tablet, in children and adolescents aged 6 to 18. About 600 participants with a history of migraine will take the drug as needed for up to one year. The main goal is to check for side…
Phase 3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with migraines: rimegepant enters final testing
Symptom relief Recruiting nowThis study tests whether rimegepant, a fast-dissolving tablet, can safely relieve migraine pain in children and adolescents aged 6 to 18. About 2,100 participants will receive either the drug or a placebo during a migraine attack. The main goal is to see if more kids become pain-…
Phase 3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Teachers' hidden struggle: could noise sensitivity be fueling job stress?
Knowledge-focused Recruiting nowThis study looks at how common hyperacusis (sensitivity to everyday sounds) and misophonia (strong negative reactions to specific sounds) are among teachers, and whether these conditions add to their work stress. Researchers will survey 500 teachers in Turkey to measure these sen…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC